Breakthrough: Nanoparticles Turn Support Cells into Neurons
Scientists at the University of South Carolina have unveiled a daring strategy to replenish lost brain cells in an Alzheimer’s‑like mouse model. Instead of trying to halt the disease’s progression, they aimed to rebuild what had already vanished: functional neurons. Their weapon of choice? A tiny, 128‑nanometre sphere packed with a custom‑designed antibody that can silence a molecular brake inside astrocytes, the star‑shaped glial cells that normally nurture and protect neurons.
Why Astrocytes Matter
Astrocytes are abundant throughout the cerebral cortex, constantly cleaning debris, regulating blood flow, and supplying nutrients. Crucially, they retain the capacity to divide, offering a built‑in reservoir that could be coaxed into a new role. Under normal conditions an intrinsic protein constantly reminds each astrocyte that it is not a neuron, effectively locking the cell in its supportive state. Removing this “brake” could unlock a hidden potential to generate fresh nerve cells from the brain’s own tissue.
The Nano‑Eraser Platform
The research team engineered a nanoball with two distinct surface ligands that enable it to cross the blood‑brain barrier. Once inside an astrocyte, the particle ruptures, releasing its antibody payload. The antibody tags the inhibitory protein, flagging it for destruction by the cell’s own waste‑disposal machinery. Because the approach does not involve permanent DNA editing, the effect is reversible: when the antibody is exhausted, the brake protein can be re‑synthesized, allowing precise temporal control over the conversion process.
From Petri Dish to Mini‑Brain
In vitro experiments with human astrocytes showed a dramatic morphological shift. The star‑shaped cells sprouted long processes, resembling immature neurons, and later displayed markers of mature neuronal identity. Electrical recordings revealed synchronized firing across the culture, indicating that the newly formed cells were not isolated oddities but integrated components of a functional network. The same nanoplatform was applied to organoids derived from human stem cells that had been deliberately damaged to mimic Alzheimer’s pathology, and these mini‑brains also regained neuronal markers and electrical activity.
Mouse Trials Deliver Promising Results
Eight‑month‑old transgenic mice, engineered to develop Alzheimer‑type damage rapidly, received two injections of the Nano‑Eraser—on day zero and again on day eight. Four weeks later, treated animals scored between 4.5 and 5 out of 5 on a nest‑building assay, a behavior that mirrors everyday problem‑solving abilities in humans. Untreated counterparts managed only a score of 1 to 1.5. In a Morris water‑maze test, the rescued mice located the hidden platform more quickly and maintained their performance even after the platform was removed, suggesting lasting improvements in spatial memory.
What This Could Mean for Human Therapy
Current Alzheimer’s drugs merely slow neuronal loss or clear toxic protein aggregates; they do not replace the cells that have already died. By converting resident astrocytes into functional neurons, the Nano‑Eraser offers a fundamentally different avenue—one that rebuilds the brain’s circuitry from within. While the findings are still confined to rodents and laboratory organoids, the technique’s reliance on a reversible, non‑genetic mechanism may ease safety concerns and accelerate translation to clinical trials.
Source: https://scientias.nl/nanodeeltjes-maken-nieuwe-neuronen-in-het-brein-van-muizen-met-alzheimer/
